Influenza A virus vaccine H5N1 (iBio)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A virus vaccine H5N1 (iBio)

Drug Alias NamePandemic avian influenza vaccineHAI-05 Influenza VaccinePlant virus derived influenza vaccine

ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza A virus infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesIbio Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIbio Inc

Active IndicationsN/A

Inactive IndicationsInfluenza A virus infections

Other Information

ATC CodeN/A